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Chemoenzymatic synthesis of 3-deoxy-3-fluoro-L-fucose and its 
enzymatic incorporation into glycoconjugates
Pablo Valverde,a,b,† Jean-Baptiste Vendeville,a,† Kristian Hollingsworth,c,† Ashley Mattey,d Tessa 
Keenan,e Harriet Chidwick,e Helene Ledru,f Kler Huonnic,a Kun Huang,d Mark Light,a Nicholas 
Turner,d Jesus Jimenez-Barbero,c,g,h M. Carmen Galan,f Martin A. Fascione,e Sabine Flitsch,d,* W. 
Bruce Turnbullc,* and Bruno Linclaua,* 
The first synthesis of 3-deoxy-3-fluoro-L-fucose is presented, which 
employs a D- to L-sugar translation strategy, and involves an 
enzymatic oxidation of 3-deoxy-3-fluoro-L-fucitol. Enzymatic 
activation (FKP) and glycosylation using an -1,2 and an -1,3 
fucosyltransferase to obtain two fluorinated trisaccharides 
demonstrates its potential as a novel versatile chemical probe in 
glycobiology.
L-Fucose is a 6-deoxy hexose naturally occurring on N- and O-
linked glycans and in glycolipids present in a large variety of 
different organisms.1, 2 It is the fifth most abundant sugar in 
mammalian carbohydrates.3 The presence or absence of 
fucosylation often crucially determines the structure of 
biologically relevant antigens such as the histo blood groups and 
Lewis-type motifs. 2,3 Fucosylated glycans such as the Human 
Milk Oligosaccharides (HMOs) play an important role in 
development, and modifications in glycan fucosylation are 
implicated in immunity, cancer, and many other important 
biological events.4-7
Hence, the importance of this sugar has spurred the 
development of L-fucose derivatives as probes or inhibitors to 
investigate and manipulate fucose biosynthesis, and 
fucosylation of glycans and glycoproteins.4, 8 Much used 
inhibitors for enzymatic fucosylation include 2-deoxy-2-fluoro-
L-fucose 1 (2DFF, Chart 1)9,10 and 6,6,6-trifluoro-L-fucose 2,11, 12 
Figure 1. Fluorinated fucose derivatives
Scheme 1. SN2-reactions at the 6-deoxysugar 3-position.
although 6-fluoro-L-fucose can also be used.9 2DFF 1 is 
commercially available, and a manufacturing process for 2 has 
been reported.13 The methyl 4-deoxy-4-fluoro-l-fucose 
anomers have been used as probes to investigate the DC-SIGN 
binding epitope, an important receptor of the immune 
system.14 Surprisingly, the synthesis of the remaining 
deoxyfluorinated l-fucose, 3-deoxy-3-fluoro-L-fucose (3DFF) 3, 
has not yet been reported.15
The synthetic strategy for 3 presents some challenges: the 
inversion of configuration (in the absence of neighboring group 
participation) that takes place during deoxyfluorination of 
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secondary alcohols is a well-known synthetic complication, 
especially when the required diastereomeric sugar is not 
available.16 This is especially so for L-sugars. In such cases, two-
step alcohol inversion prior to deoxyfluorination is required, 
which is often not high-yielding, and all other alcohol groups 
must be suitably protected. For 3DFF 3 synthesis, a suitably 
activated 6-deoxy-L-allose intermediate needs to be accessed. 
Unfortunately, Shimabukuro et al have reported that such an 
SN2 reaction is very challenging (Scheme 1).
17 Even with an 
excellent selenide nucleophile, attempted triflate displacement 
in 5 mainly led to the elimination product 6. Speculating that 
the SN2 reaction may be stereoelectronically disfavoured as 
predicted by the Richardson-Hough rules,18 and aiming to 
hamper the elimination process, a less electron withdrawing 4-
OH protecting group and a cyclic protecting group at C1/2 were 
installed. Now, SN2 reaction was observed in excellent yield, but 
at the cost of a very long synthesis of the precursor 8. In fact, to 
the best of our knowledge, deoxyfluorination to give 3-
fluorinated fucopyranose (or galactopyranose) products has not 
yet been reported. In their recent syntheses of 3-deoxy3-fluoro-
D-fucosamine analogues,19 Kulkarni et al. circumvented the 
issue by using via 3-OH inversion of the quinovose derivative 10 
(equatorial 4-OR group), then deoxyfluorination to give the 
fluorinated D-quinovosamine derivative 11, and finally followed 
by installation of the stereochemistry at C4 by another inversion 
to obtain the 3-fluorinated D-fucosamine derivative 12. Hence, 
this requires multiple inversion steps, and as L-configured 
quinovose is less available, this route is less suitable for the 
synthesis of L-3. 
Sugar epoxides are frequently used for site-selective 
fluorination. On a pyranose ring, these reactions are usually 
very regioselective due to the stereo-electronically required 
axial attack (Furst-Plattner rule).20 However, in L-fucose the 
substituent at the 3-position is equatorial, ruling out this option 
for the synthesis of 3. 
As part of our studies in the use of fluorinated carbohydrates as 
substrates for enzymatic glycosylations, a practical synthesis of 
3DFF 3 was required. The synthetic route in Scheme 1 was 
deemed unsuitable, given the number of steps involved. In 
addition, the much reduced nucleophilicity of fluoride 
compared to selenide was a potential complication that 
discouraged us from proceeding this way. Driven by the desire 
to start from a low-cost starting material, and to avoid the 
requirement of prior inversion of a hydroxyl group in order to 
arrive at the correct C–F configuration, a synthetic scheme 
(Scheme 1) was devised that relied on a d- to l-sugar translation. 
Hence, starting from a suitably protected glucoside 13, 
fluorination and ring opening would lead to a 4-deoxy-4-fluoro-
d-galacto-configured intermediate A. Swapping C1 into C6 (D- 
to L-conversion), followed by respective oxidation/reduction 
then would lead to the desired fucose derivative 3. The 
aldehyde reduction was envisaged via a dithioacetal 
intermediate. Hence, this strategy is a variation on Barros’ d-Gal 
to L-Fuc synthesis.21, 22 Other chemical D- to L-sugar syntheses 
include Okamoto’s synthesis of L-Gal from D-Gal,15 and Fleet’s 
synthesis of L-Glc from D-Glc.23
To that end, cheap, commercially available methyl -D-
glucoside 13 (Scheme 3) was selectively protected at the 6-
position, upon which treatment with DAST led to selective 
conversion of the 4-OH group as reported by Card.24 Without 
prior anomeric deprotection, the methyl galactoside derivative 
14 was converted to the corresponding ring-opened 
dithioacetal, using an adapted procedure from Redlich and 
Kölln.25 The acidic conditions of this reaction also led to the 
desired trityl hydrolysis, leading to 15. Unfortunately, all 
attempts to reduce the dithioacetal group led to the formation 
of the desired fucitol derivative 16 together with an unidentified 



















































Scheme 2. Synthesis of 3-deoxy-3-fluoro-L-fucitol, with unsuccessful selective oxidation 
of the primary alcohol.
After some experimentation, it was found that acetonide 
protection of 15 to give 17 allowed for clean dithiane reduction, 
leading to pure 16, albeit in moderate yield. Acetonide 
hydrolysis then afforded pure 16 of which a crystal structure 
could be obtained. Unfortunately, despite relatively close 
precedence in the literature,26-28 all attempts to effect selective 
oxidation at the primary position gave no result. TEMPO 
oxidation proved inefficient in converting 3-deoxy-3-fluoro-L-
fucitol into 3, returning the starting material regardless of the 
conditions used (NaOCl or trichloroisocyanuric acid (TCCA) 
oxidant). The use of Dess-Martin periodinane did lead to 
conversion, with NMR analysis indicating a mixture of cyclised 
products, however, no anomeric signals could be detected 
indicating overoxidation to lactone derivatives. It was not 
possible to adjust reaction times to prevent overoxidation. 
Selective hydrolysis of the terminal acetonide in 17 could also 
not be achieved.
At this point it was decided to investigate an enzymatic 
oxidation protocol, as opposed to developing a different 
protecting group strategy. The Galactose Oxidase (GOase) 
enzyme was identified as a possible solution. While GOase itself 
is strictly limited to oxidizing the C6 hydroxyl of non-reducing 
galactosides and a small number of aromatic primary alcohols, 
previous engineering efforts have greatly expanded its 
substrate scope to a large number of primary and secondary 
alcohols.29, 30 In this enzymatic alcohol-oxidation protocol, H2O2 
is produced which is converted back to O2 using catalase, whilst 
Horse Radish peroxidase (HRP) is required for GOase activation. 
Four easily expressed (E. coli) variants of GOase (M1, M3, F2, and 
M3-5), selected to provide the greatest substrate scope, were 
tested against 16 for activity (Table 1) using a coupled 
colorimetric assay that measures the generated H2O2. In this 












































































Journal Name  COMMUNICATION
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
assay HRP utilizes H2O2 (generated from the GOase oxidation) 
to oxidize 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid, 
ABTS) to a colored product.31 The variants displayed a wide 
range of activities: the M1 variant was unable to oxidize the 
fluorinated fucitol, with M3 and M3-5 displaying very low specific 
activity. However, the F2 variant provided significant activity 
useable for scale-up. This F2 variant was originally generated 
from mutagenesis of the Arnold Group M1 variant,
32 and is 
known to be able to oxidize the primary hydroxyl group of a 
large panel of saccharides.29 Interestingly, the specific activity 
of the F2-variant towards 16 is higher than its activity towards 
GlcNAc, which it was engineered towards.29
Table 1. GOase variants screened against 25mM 3-Fluoro Fucitol using the HRP-ABTS 
assay.






























Scheme 3. Successful synthesis and crystal structure of 3-deoxy-3-fluoro-l-fucose 3
Following a successful analytical scale biotransformation 
showing full conversion (not shown), we were delighted to 
observe, after overnight incubation at 25 mM substrate loading, 
successful conversion of 3-deoxy-3-fluoro-L-fucitol to 3-deoxy-
3-fluorofucose 3 in good yield (Scheme 3). Pleasingly, sugar 3 
was crystalline, and was found to crystallize as the -anomer.
In aqueous solution (D2O), 3 existed as a 1:2 mixture of anomers 
in favor of the -anomer, which is essentially the same as the 
ratio of the nonfluorinated fucose anomers.33 Analysis of the 
coupling constants (Figure 1) indicated that both anomers exist 
in the expected 1C4 conformation: the 
3JH1-H2 value was large for 
the -anomer and small for the -anomer, while both anomers 
showed a large vicinal coupling between H2 and H3. The 
equatorial position of the fluorine was confirmed by the small 
3JF3-H4 values. Interestingly, a large long-range coupling between 























-anomer of 3 -anomer of 3
H
5.5 Hz
Figure 2. 1H NMR analysis of 3 in D2O
Next, it was investigated whether the incorporation of 3-deoxy-
3-fluorofucose 3 into glycoconjugates containing common 
motifs found in human biology was possible. Contrary to the 
well-studied 2-fluorination such as in compound 1, a known 
inhibitor of fucosylation in vivo,9 3-deoxy fluorination would be 
expected to have less of an influence on fucosylation reactions 
and as such would be predicted to allow for fluorine 
incorporation into glycoconjugates. First the formation of the 
required fucosyl donor, GDP-3-deoxy-3-fluorofucose 19 
(Scheme 4), was achieved using fucokinase/L-fucose-1-P-
guanylyltransferase (FKP) from Bacteroides fragilis.34 This 
bifunctional enzyme converts 3-deoxy-3-fluorofucose 3 into 3-
deoxy-3-fluorofucosyl phosphate 18, and then into GDP-3-
deoxy-3-fluorofucose 19 which could be confirmed by mass 
spectrometry. This demonstrates for the first time that 3-deoxy-
3-fluorofucose 3 is a substrate for FKP.
The synthesis of the Lewis x analogue 22 was then attempted 
from the crude fucosyl donor 19 using an -1,3-
fucosyltransferase from H. Pylori.35 To our delight, the product 
22 was isolated in 50% yield after purification showing that 3-
deoxy-3-fluorofucose 3 is successfully accepted as substrate. In 
addition, the synthesis of the type 1 blood group antigen 
analogue 23 from the fucosyl donor 19 was also successful using 
a different fucosyltransferase (-1,2).36 As a result of limited 































































Scheme 4. Enzymatic synthesis of Lewis x analogue 22 and type 1 blood group 
antigen analogue 23
In conclusion, we report the first synthesis of 3-deoxy-3-fluoro-
L-fucose 3 using a D- to L-sugar conversion strategy, in seven 
steps starting from a cheap d-glucose starting material. Key 
aspects of this synthesis are the avoidance of an alcohol 
inversion operation prior to the deoxyfluorination step, and a 
final regioselective enzymatic oxidation to the desired 3-deoxy-
3-fluoro-L-fucose 3 using a galactose oxidase variant. Contrary 
to the 2-fluoroisomer 1, we have shown that 3 can be 
successfully activated using the kinase FKP to achieve 
conversion to the corresponding GDP-3-deoxy-3-fluoro-l-fucose 
19, which furthermore is accepted by both an -1,3- and -1,2-
fucosyltransferase to lead to fluorinated Lewis x 22 and type 1 
blood group antigen 23. This work demonstrates a novel 
approach to deoxyfluorinated sugar synthesis, as well as the 
potential of 3-deoxy-3-fluoro-L-fucose 3 as a metabolic probe 
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that is highly complementary to the widely used 2-fluoro isomer 
1.
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